Regulatory

  1. Mitigate Clinical Risk In Cell Therapy Development With A GMP Compliant Process 4/21/2025

    Help shape the future of medicine by building better, safer cell therapies. See how expertise in scalable, GMP-compliant cell engineering can effectively mitigate clinical development risks.

  2. A Tool To Support Your Everyday Analytical Needs 12/2/2024

    Discover the impact of a cloud-based software platform with practical applications for instrument integration, bioreactor analysis, and more.

  3. Overcoming Development And Manufacturing Challenges 7/13/2023

    Maggie Chen, Senior Director, Manufacturing & MSAT, AGC Biologics, discusses the importance of maintaining relationships throughout the project timeline as well as how to move to the standardization approach.

  4. Nuvia Q & S High Capacity Ion Exchangers For Biotherapeutic Purification Video

    Bio-Rad now offers two very high capacity ion exchangers: Nuvia S, which can be used for capture and/or intermediate polishing; and Nuvia Q, which can be used for intermediate and/or final polishing.

  5. HyPerforma 5:1 Single-Use Bioreactor (S.U.B.) Setup And Installation Part 3 5/7/2020

    This video is part 3 of 3 videos that cover setup and installation topics related to the HyPerforma 5:1 Single-Use Bioreactor, or S.U.B. In this video we will cover probe assembly, making CPC AseptiQuik connections, probe insertion.

  6. Building A Better Mousetrap For Metabolic Disorders 10/29/2024

    Punit Dhillon explains how Skye Bioscience is developing the next generation of anti-obesity therapeutics by targeting CB1 inhibition.

  7. Bio & The Business Of Aging with Life Biosciences' Jerry McLaughlin 9/7/2023

    Core to the clinical-stage biopharma Life Biosciences belief set is that "contrary to popular belief, aging is not caused by random wear and tear, but instead is caused by a discrete set of biological mechanisms that can be targeted therapeutically.”

  8. Scale Your Process Directly From 3L To 2,000L Blindfolded 12/11/2019

    In the biotech industry, you need to move quickly and use resources efficiently to advance a drug candidate into the clinic and ultimately onto the market. Being able to quickly produce a batch at the right time and at the right size is essential to support development and get to the finish line faster. We developed a strategy to enable a direct, efficient and robust tech transfer of a monoclonal antibody production process from a 3L bioreactor to 2000L without the need for any intermediate volumes.

  9. The Current State Of Alzheimer's Disease Therapeutics 2/10/2025

    Acumen president and CDO Jim Doherty, Ph.D., discusses recent setbacks and current opportunities for Alzheimer’s disease drug development.

  10. Bioprocess Automation And Data Management Solutions 6/24/2020

    We offer a portfolio of Thermo Scientific bioprocess equipment and automation solutions that are designed to reduce the complexity involved in scale-up and technology transfer, and enable the data management that is required of GMP-certified facilities for product quality, system validation, and record-keeping. We help you establish, transfer, and maintain recipes, alerts, batch records, and historian data with a consistent user interface from R&D to process development to GMP manufacturing.